Expert Interview
A discussion about managing patients with obesity and other overweight-related health problems. Focusing on the standard of care and the potential of Eli Lily's diabetes/weight loss drug, tirzepatide
Ticker(s): LLY, NVOInstitution: University of Utah Medical Center
- Director of the obesity Medicine program and co-director of the Comprehensive weight management program at the University of Utah
- Sees 200 patients a month for medical weight management and 100 of those have types 2 diabetes
- Research and clinical interests in medical weight management, genetics of obesity, and chronic disease management
Do you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
